Introduction
A fundamental tenet of exercise physiology is that blood flow (BF) increases following exercise onset to meet the rising skeletal muscle energetic demands. This hyperemic response is mediated by a host of vasodilatory controllers (Joyner and Wilkins, 2007) and it is now widely accepted that nitric oxide (NO) plays a deterministic role in regulating not only O 2 delivery (QO 2 ) (Hirai et al. 1994 ; reviewed by Joyner and Tschakovsky, 2004) , but also O 2 utilization ( ) within the skeletal muscle (Andrade et al. 1998; Larsen et al 2012) . A growing body of evidence suggests that ingestion of inorganic nitrate (NO 3 -), for example via beetroot juice (BR), can, following a step-wise reduction, elevate NO bioavailability and thus impact skeletal muscle hemodynamic and metabolic function during exercise (Larsen et al. 2007; Bailey et al. 2009; Vanhatalo et al. 2010; Kenjale et al. 2011; Lansley et al. 2011a,b; Ferguson et al. 2013a,b) .
In humans, NO 3 -supplementation via BR reduces blood pressure and enhances exercise tolerance in both healthy (Bailey et al. 2009; Vanhatalo et al. 2010; Lansley et al. 2011a,b; Cermak et al. 2012; Wylie et al. 2013b) and patient populations (i.e., peripheral arterial disease, Kenjale et al. 2011) . These effects appear to have a dose-dependent response with no additional improvement in exercise tolerance after ingesting BR containing 16.8 compared to 8.4 mmol NO 3 - (Wylie et al. 2013a ). The precise mechanisms for these improvements are not yet fully understood. However, recent investigations using murine models implicate enhanced exercising muscle BF (i.e., ↑QO 2, Ferguson et al. 2013a) 
Methods

Animal selection and care
Thirty-one young adult male Sprague-Dawley rats (~3-4 months of age, Charles River Laboratories, Wilmington, MA,USA) were used in this investigation. Rats were maintained in accredited animal facilities at Kansas State University on a 12/12 hr light-dark cycle with food and water provided ad libitum. All procedures were approved by the Institutional Animal Care and Use Committee of Kansas State University and conducted according to National Institutes of Health guidelines. All rats were familiarized with running on a custom-built motor-driven treadmill for 5 min/day at a speed of 20 m/min up a 5% grade for ~5 days.
Supplementation protocol
Rats were randomly assigned to receive 5 days of BR supplementation with either a low that used by Jones and colleagues (Bailey et al. 2009; Vanhatalo et al. 2010; Lansley et al. 2011a,b) after accounting for the resting metabolic rate of rats (~7x that of humans, Henson et al. 1987; Musch et al. 1988) . In an effort to minimize the unnecessary utilization of additional animals, both control and BRHD data presented herein represent a randomly selected subset of animals published recently. The BRHD data represent a NO 3 -dose of 1 mmol/kg/day and demonstrate a significant vascular effect of supplementation (Ferguson et al. 2013ab) . Data from the BRLD group were obtained within the same time-frame as control and BRHD groups presented in Ferguson et al. (2013ab, e.g. within 16 weeks) . In this way any potential seasonal differences or variations in rat-chow content were avoided.
Surgical instrumentation
Rats were anaesthetized with a 5% isoflurane-O 2 mixture and maintained subsequently on 3% isoflurane-O 2 . The carotid artery was isolated and cannulated with a catheter (PE-10 connected to PE-50, Intra-Medic polyethylene tubing, Clay Adams Brand, Becton, Dickinson and Company, Sparks, MD) for the measurement of MAP and HR, infusion of the phosphorescent probe (see below), and arterial blood sampling. A second catheter was placed in the caudal artery. The incisions were then closed and rats were given >1 hr to recover (Flaim et al. 1984) .
Protocol 1: Measurement of hindlimb skeletal muscle blood flow
After recovery, rats were placed on the treadmill and the caudal artery catheter was connected to a 1 ml syringe chambered in a Harvard infusion/withdrawal pump (model 907, Cambridge, MA, USA). The carotid artery catheter was connected to a pressure transducer (Gould Statham P23ID, Valley View, OH, USA) maintained at the same height as the animal.
Exercise was initiated and treadmill speed was increased progressively over a ~30 s period to a speed of 20 m/min (5% grade, ~60% O 2 max; Musch et al. 1988) . The rat continued to exercise for another 2.5 min until a total time of 3 min was reached. At 3 min the Harvard pump was activated and withdrawal was initiated at a rate of 0.25 ml · min Following a minimum 1 hr recovery period, a second microsphere infusion (differently radio-labeled than the first) was performed while the rat sat quietly on the treadmill for the determination of resting BF, HR and MAP. This experimental strategy (i.e. exercise before rest)
mitigates potential influences of the pre-exercise anticipatory response on resting skeletal muscle BF measurements (Armstrong et al. 1989) .
Protocol 2: Measurement of spinotrapezius muscle PO 2 mv
Following the second (resting) microsphere infusion, rats were anesthetized progressively using diluted pentobarbital sodium anesthesia (administered into the caudal artery catheter to effect) with the level of anesthesia monitored continuously via the toe-pinch and blink reflexes.
Rats were then placed on a heating pad to maintain core temperature at ~38 °C (measured via rectal probe). Overlying skin and fascia were reflected carefully from the mid-dorsal caudal region of each rat and the right spinotrapezius muscle was carefully exposed in a manner that ensured the integrity of the neural and vascular supply to the muscle (Bailey et al. 2000) . Silver wire electrodes were sutured (6-0 silk) to the rostral (cathode) and caudal (anode) regions of the muscle. The exposed spinotrapezius muscle was continuously superfused with a warmed (38°C)
Krebs-Henseleit bicarbonate buffered solution equilibrated with 5% CO 2 -95% N 2 and surrounding exposed tissue was covered with Saran wrap (Dow Brands, Indianapolis, IN). The spinotrapezius muscle was selected specifically based on its mixed muscle fiber-type composition and citrate synthase activity close to that found in human quadriceps muscle (Delp & Duan 1996; Leek et al. 2001 ).
The phosphorescent probe palladium meso-tetra (4 carboxyphenyl)porphyrin dendrimer (R2: 15-20 mg·kg -1 dissolved in 0.4 ml saline) was infused via the carotid artery catheter. After a brief stabilization period (~10 min), the common end of the light guide of a frequency domain phosphorometer (PMOD 5000, Oxygen Enterprises, Philadelphia, PA) was positioned ~2-4 mm superficial to the dorsal surface of the exposed right spinotrapezius muscle over a randomly selected muscle field absent of large vessels thus ensuring that the region contained principally capillary blood. PO 2 mv was measured via phosphorescence quenching (see below) and reported at 2 s intervals throughout the duration of the 180 s contraction protocol (1 Hz, ~6 V, 2 ms pulse duration) elicited via a Grass stimulator (model S88, Quincy, MA). Following the contraction period it was ensured that PmvO 2 returned to baseline values (indicative of preserved vasomotor function). Rats were euthanized via pentobarbital sodium overdose (≥50 mg/kg administered into the carotid artery catheter).
PO 2 mv measurement and curve-fitting
The Stern-Volmer relationship allows the calculation of PO 2 mv through the direct measurement of a phosphorescence lifetime via the following equation (Rumsey et al., 1988) :
where k Q is the quenching constant and τ and τ are the phosphorescence lifetimes in the absence and τ is 601 µs (Lo et al., 1997) and these characteristics do not change over the physiological range of pH and temperature in the rat in vivo and, therefore, the phosphorescence lifetime is determined directly by the O 2 pressure (Rumsey et al., 1988; Lo et al., 1997) .
The R2 phosphorescent probe binds to albumin, and consequently, is uniformly distributed throughout the plasma. A previous study from our laboratory investigated systematically the compartmentalization of R2 and confirmed that it remains within the microvasculature of exposed muscle over the duration considered in the present experiments, thereby ensuring a valid PO 2 mv measurement (Poole et al., 2004) .
Curve-fitting of the measured PO 2 mv responses was performed with commercially available software (SigmaPlot 11.01, Systat Software, San Jose, CA) and the data were fit with either a one-or two-component model as described below:
where PO 2 mv (t) represents the PO 2 mv at any given time t, PO 2 mv (BL) corresponds to the precontracting resting baseline PO 2 mv, Δ 1 and Δ 2 are the amplitudes for the first and second components, respectively, TD 1 and TD 2 are the time delays for each component, and τ 1 and τ 2 are the time constants (i.e., time to 63% of the final response value) for each component. Goodness of fit was determined using the following criteria: 1) the coefficient of determination, 2) sum of the squared residuals, and 3) visual inspection and analysis of the model fits to the data and the residuals. The mean response time (MRT) of the kinetics response was calculated for the first component in order to provide an index of the overall principal kinetics response according to the following equation:
where TD 1 and τ 1 are as described above. The delta of the initial PO 2 mv fall following contractions onset was normalized to τ 1 (Δ 1 PO 2 mv /τ 1 ) to provide an index of the relative rate of fall. Additionally, the time taken to reach 63% of the initial PO 2 mv fall was determined independently from the modeling procedures (T 63 ) to ensure appropriateness of the model fits.
Specifically, the raw PO 2 mv data were interpolated, and the time coinciding with 63% of the total amplitude (Δtotal PO 2 mv) was determined.
Determination of BF and VC
Following euthanasia, the thorax of each rat was opened and placement of the carotid artery catheter was confirmed before the internal organs and individual muscles and muscle parts of the hindlimb were identified and excised. Upon removal, tissues were weighed and placed promptly into counting vials. Radioactivity of each tissue was determined with a gamma scintillation counter (Packard Auto Gamma Spectrometer, model 5230, Downers Grove, IL, USA). Tissue BF was then calculated using the reference sample method (Musch & Terrell, 1992 ) and expressed as ml/min/100 g. 
Statistical analysis
Data are presented as mean ± standard error of the mean (SEM). Results were compared within (rest vs. exercise) and between (control vs. BRLD vs. BRHD) using mixed 2-way analysis of variance (ANOVA) with Student-Newman-Keuls post hoc tests where appropriate.
Significance was accepted at P<0.05.
Results
There were no between-group differences in the total hind-limb muscle/body mass ratio Similarly, there were no differences in resting BF or VC in any of the 28 individual hindlimb muscles or muscle parts (Table 1) .
Total exercising hindlimb muscle BF and VC were greater in BRHD rats when compared to BRLD and control rats (Figure 3) . Specifically, BRHD supplemented rats had greater BF in 15, and VC in 20, of the 28 individual hindlimb muscles and muscle parts (Table 2 ) when compared to control and BRLD rats. There were no between-group differences in BF or VC at rest or during exercise to organs of the splanchnic region (Table 3 ).
Protocol 2: PO 2 mv parameters
Representative raw PO 2 mv profiles of control, BRLD and BRHD rats are presented in 
Discussion
The principal original finding of this investigation is that low dose NO Lewington et al. 2002; Law et al. 2003; Lawes et al. 2003; Larsen et al. 2007 Larsen et al. ,2010 , these findings have strong potential clinical significance. It is also pertinent that employing low dose inorganic NO 3 -supplementation may avoid or reduce the opportunity for development of NO 3 -tolerance and endothelial dysfunction Omar et al. 2012 ) which occur especially after chronic administration of organic NO 3 -(see Wylie et al. 2013a for discussion).
Relationship to existing literature
The randomly selected subset of data from results initially reported from our laboratory (Ferguson et al. 2013a ) demonstrate clearly the effects of BRHD as regards elevated skeletal muscle(s) BF and VC and reduced MAP during treadmill running. Also, as demonstrated in Figure 4 , PO 2 mv kinetics were slowed significantly and PO 2 mv decreased less during contractions of the spinotrapezius muscle, effectively raising the microvascular O 2 driving pressure especially across the transition period when mitochondrial O 2 uptake would be rising most rapidly (Ferguson et al. 2013b) . These effects can be explained by the greater O 2 delivery combined with a reduced mitochondrial O 2 utilization at a given workload as demonstrated in intact humans (Larsen et al. 2007; Bailey et al. 2009; Larsen et al. 2010; Wylie et al. 2013a ) as well as in isolated mitochondria (Larsen et al. 2012) . With respect to the BRLD and based upon the dose-response relationship reported by Wylie et al. (2013a) , where a graded fall in MAP was observed from 4.2 to 8.4 mmol NO 3 -(supplemented via BR with no additional decrease at 16.8 mmol), we were surprised that, in rats, MAP fell to the same extent (i.e., ~10 mmHg) with both doses. Paramount to setting the NO 3 -supplement doses herein was the consideration of the faster metabolic rate found in the resting rat (~27 ml/kg/min, Musch et al. 1988 ) when compared to humans (3.5ml/kg/min, i.e. ~7-8 fold higher per unit mass, Henson et al. 1987) . Taking this into account, the doses employed (i.e., BRLD, 0.3; BRHD, 1 mmol/kg/day) correspond broadly to 3.2 and 7.4 mmol/day, respectively in humans. Thus, with respect to species differences, the NO 3 -derived hypotensive response becomes saturated at lower doses in rats than in their human counterparts. This effect is very different from the skeletal muscle vascular response and that of PO 2 mv which are manifested only at the higher dose.
Mechanisms for reduction of mean arterial pressure
The increased VC observed in the skeletal muscle(s) of BRHD rats explain, at least in part, the reduction in MAP found at the higher dose. However, in marked contrast, skeletal muscle VC and BF were unchanged for BRLD (which was not unexpected given that circulating NO 3 -/NO 2 -levels were not different from control values) and thus, the reduced MAP for these animals must have a different explanation. There is evidence that NO bioavailability (from both endothelial and neuronal nitric oxide synthase, eNOS and nNOS) in higher cardiovascular neural control centers, for example the RVLM, impacts sympathetic outflow and controls, or at least influences, MAP regulation and can lead to a reduction and/or redistribution of cardiac output (e.g. Mayorov, 2005; Gao et al. 2008) . Although not measured in this investigation, it is possible that BRLD may have altered NO bioavailability in the RVLM. Indeed, elevated NO bioavailability via overexpression of eNOS in the RVLM induces significant hypotension by elevating gamma-aminobutyric acid (GABA) production (Kishi et al. 2001) . Thus, one putative mechanism for the hypotensive response invoked by BRLD relates to increased NO bioavailability in the RVLM from non-nNOS/eNOS dependent sources which may ultimately reduce sympathetic outflow. A greater NO 3 -dose may intensify this effect which could be responsible, at least in part, for the elevated renal BF and VC seen in BRHD rats herein.
Furthermore, the presence of antioxidants in the BR supplement may contribute to this effect (Gao et al. 2007 ) and thus play a synergistic role with NO 3 -. This novel aspect of BR and NO 3 -mediated cardiovascular control carries clinical implications for those suffering from renal vascular diseases (Lundberg et al. 2008; Carlstöm et al. 2011) and warrants future investigation. 
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; Lewington et al. 2002; Law et al. 2003; Lawes et al. 2003; Larsen et al. 2007 Larsen et al. , 2010 Tsuchiya et al. 2010; CarlstrÖm et al. 2011) . Given the sensitivity of the RVLM to NO bioavailability (Mayorov, 2005; Gao et al. 2008) , it seems logical to postulate an interaction between NO 3 -, NO 2 -and central cardiovascular control centers located in the brain (i.e. RVLM).
Understanding these interactions will further provide a mechanistic linkage between elevated NO 3 -ingestion and the improved cardiovascular and metabolic function seen in humans (Bailey et al. 2009 Larsen et al. 2010; Kenjale et al. 2011; Vanhatalo et al. 2011; Masschelein et al.2012; Wylie et al. 2013b ) and animals (Ferguson et al. 2013a,b; Hernandez et al. 2013 ) and thus should be the focus of future investigations. Table 3 . Effects of low dose and high dose BR supplementation on kidney and splanchnic region organ BF (ml/min/100g) and VC (ml/min/100g/mmHg) at rest and during exercise. 
